BRIEF-Ironwood Pharmaceuticals Q3 Revenue USD 91.592 Million Vs. IBES Estimate USD 91.2 Million

Reuters
07 Nov 2024

Nov 07 (Reuters) - Ironwood Pharmaceuticals Q3 EPS USD 0.02. * Q3 adjusted net income USD 3.869 million vs. IBES estimate USD 15.3 million * Q3 basic EPS USD 0.02 * Q3 net income USD 3.646 million * Q3 adjusted EBITDA USD 26.159 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10